A History of Outperforming Analyst Forecasts and Beating the Odds: Revelation Biosciences Inc. (REVB)

Revelation Biosciences Inc. (NASDAQ: REVB) stock jumped 1.82% on Thursday to $1.12 against a previous-day closing price of $1.10. With 0.64 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.75 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.2300 whereas the lowest price it dropped to was $1.0500. The 52-week range on REVB shows that it touched its highest point at $67.90 and its lowest point at $0.95 during that stretch. It currently has a 1-year price target of $15.00.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of REVB was up-trending over the past week, with a rise of 3.70%, but this was up by 3.70% over a month. Three-month performance dropped to -47.91% while six-month performance fell -84.91%. The stock lost -94.18% in the past year, while it has lost -83.17% so far this year. A look at the trailing 12-month EPS for REVB yields -16.20 with Next year EPS estimates of -2.10. For the next quarter, that number is -1.75. This implies an EPS growth rate of -12.70% for this year and 89.70% for next year.

Float and Shares Shorts:

At present, 5.77 million REVB shares are outstanding with a float of 5.36 million shares on hand for trading. On May 14, 2023, short shares totaled 68400.0, which was 1.18% higher than short shares on Apr 13, 2023. In addition to Mr. James M. Rolke as the firm’s CEO & Director, Mr. Chester Stanley Zygmont III serves as its CFO & Corp. Sec.

Institutional Ownership:

Through their ownership of 1.85% of REVB’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 2.45% of REVB, in contrast to 17.87% held by mutual funds. Shares owned by individuals account for 0.00%. As the largest shareholder in REVB with 4.73% of the stake, Anson Funds Management LP holds 213,509 shares worth 213,509. A second-largest stockholder of REVB, Sabby Management LLC, holds 180,431 shares, controlling over 4.00% of the firm’s shares. Walleye Capital LLC is the third largest shareholder in REVB, holding 174,685 shares or 3.87% stake. With a 0.00% stake in REVB, the Fidelity Nasdaq Composite Index F is the largest stakeholder. A total of 45 shares are owned by the mutual fund manager.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, REVB reported revenue of $0.00 and operating income of -$1.86M. The EBITDA in the recently reported quarter was -$1.85M and diluted EPS was -$4.20.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for REVB since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With REVB analysts setting a high price target of $15.00 and a low target of $15.00, the average target price over the next 12 months is $15.00. Based on these targets, REVB could surge 1239.29% to reach the target high and rise by 1239.29% to reach the target low. Reaching the average price target will result in a growth of 1239.29% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded REVB stock several times over the past three months with 2 Buys and 0 Sells. In these transactions, 51,500 shares were bought while 0 shares were sold. The number of buy transactions has increased to 2 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 51,500 while 0 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *